Publication | Closed Access

Vitamin E-based prodrug self-delivery for nanoformulated irinotecan with synergistic antitumor therapeutics

Cell-based Drug DeliveryNanomedicineMedicinal ChemistryTherapeutic NanomaterialsMedicinePharmaceutical NanotechnologyNano-drug DeliveryPharmacotherapySynergistic Antitumor TherapeuticsDrug Delivery SystemPharmacologyRadiation OncologyDrug Discovery